This hottest twist from the Lykos Therapeutics saga threatens A significant overhaul of the business’s method and direction, with Musk ally and billionaire Trader Antonio Gracias appearing to desire to get the business again toward its nonprofit drug advancement roots and a far more Doblinite philosophy.Disclaimer: copyright Spotlight and its mum